Literature DB >> 22226767

Identification of metabolites of Si-Ni-San, a traditional Chinese medicine formula, in rat plasma and urine using liquid chromatography/diode array detection/triple-quadrupole spectrometry.

Zhixiang Yan1, Ying Chen, Tianxue Li, Jie Zhang, Xinghao Yang.   

Abstract

Si-Ni-San (SNS) is a widely used traditional Chinese medicine formula (TCMF) in treating various diseases. However, the in vivo integrated metabolism of its multiple components remains unknown. In this paper, a liquid chromatography coupled with diode array detection and triple-quadrupole spectrometry (LC-DAD-MS/MS) method was developed for detection and identification of SNS metabolites in rat plasma and urine at a normal clinical dosage. Accurate structural elucidation was performed using MS/MS, UV data and n-octanol/water partition coefficient. Based on the proposed strategy, 36 absorbed compounds and 29 metabolites in plasma and 33 metabolites in urine were detected by a highly sensitive MRM method. Our results indicated that phase II reactions (e.g., methylation, glucuronidation and sulfation) were the main metabolic pathways of gallic acid and flavanones, while phase I reactions (e.g., hydroxylation) were the major metabolic reaction for triterpenoid saponins. The metabolite profile analysis of SNS provided a comprehensive understanding of the in vivo metabolic fates of constituents in SNS. Moreover, the results in this work demonstrated the present strategy based on the combination of chromatographic, spectrophotometric, mass-spectrometric, and software prediction to detect and identify metabolites was effective and reliable. And such a strategy may also be extended to investigate the metabolism of other TCMF.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226767     DOI: 10.1016/j.jchromb.2011.12.017

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MSn.

Authors:  Fang Li; You-Bo Zhang; Xia Wei; Chun-Hong Song; Ming-Qi Qiao; Hui-Yun Zhang
Journal:  Mol Med Rep       Date:  2016-04-04       Impact factor: 2.952

Review 2.  Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review.

Authors:  Dan-Dan Feng; Tao Tang; Xiang-Ping Lin; Zhao-Yu Yang; Shu Yang; Zi-An Xia; Yun Wang; Piao Zheng; Yang Wang; Chun-Hu Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-20       Impact factor: 2.570

3.  A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.

Authors:  Hai-Yang Fang; Hua-Wu Zeng; Li-Mei Lin; Xing Chen; Xiao-Na Shen; Peng Fu; Chao Lv; Qun Liu; Run-Hui Liu; Wei-Dong Zhang; Jing Zhao
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

4.  The in vitro estrogenic activity of the crude drugs found in Japanese herbal medicines prescribed for menopausal syndrome was enhanced by combining them.

Authors:  Zeyun Wang; Seiji Kanda; Takaki Shimono; Dambajamts Enkh-Undraa; Toshimasa Nishiyama
Journal:  BMC Complement Altern Med       Date:  2018-03-23       Impact factor: 3.659

5.  Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry for Identification of In Vitro and In Vivo Metabolites of Bornyl Gallate in Rats.

Authors:  Wei Lan; Liujiao Bian; Xinfeng Zhao; Pu Jia; Xue Meng; Yizhen Wu; Shixiang Wang; Sha Liao; Jie Yu; Xiaohui Zheng
Journal:  J Anal Methods Chem       Date:  2013-03-27       Impact factor: 2.193

6.  The Profiling and Identification of the Absorbed Constituents and Metabolites of Guizhi Decoction in Rat Plasma and Urine by Rapid Resolution Liquid Chromatography Combined with Quadrupole-Time-of-Flight Mass Spectrometry.

Authors:  Hongjun Xiang; Lishi Zhang; Jiannan Song; Bin Fan; Yinglan Nie; Dong Bai; Haimin Lei
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.